Biostage's IPO

Biostage raised a round of funding on November 02, 2013. Investors include Public.

Biostage, formerly Harvard Apparatus Regenerative Technology, is a biotechnology company developing bioengineered organ implants based on the company's new Cellframe technology. Biostage's Cellframe …

Articles about Biostage's IPO: